Publication:
Experience with Treatment of Retroperitoneal Fibrosis: Collaboration of Urology and Nephrology Departments for 26 years in Marmara University

Simple item page
dc.contributor.authorŞEKERCİ, ÇAĞRI AKIN
dc.contributor.authorsSekerci, Cagri Akin; Tanidir, Yiloren; Ozgen, Mahir Bulent; Koc, Mehmet; Akbal, Cem; Simsek, Ferruh
dc.date.accessioned2022-03-12T20:30:56Z
dc.date.available2022-03-12T20:30:56Z
dc.date.issued2017
dc.description.abstractOBJECTIVE: Retroperitoneal fibrosis (RPF) is a rare condition characterized by the presence of inflammation and fibrosis in the retroperitoneum. This study describes our multidisciplinary approach and our results. MATERIAL and METHODS: Patients diagnosed with RPF at Marmara University between January 1990 and May 2007 were evaluated. Etiologies, demographic characteristics, renal functions, treatments and prognoses of each patient were recorded and data were analyzed. RESULTS: Of all patients, five were female, 15 were male and the mean follow-up was 11.3 years (1-18 years). Six patients were operated unilaterally and five were operated bilaterally with ureterolysis. Median creatinine values at diagnosis were 2.75 mg/dl (0.7-6.9 mg/dl) in females, 3.2 mg/dl (0.84-7.2 mg/dl) in males and 3.11 mg/dl (0.7-7.2 mg/dl) in the whole group. Median baseline creatinine level after surgery (n=11) was found to decrease from 3.63 mg/dl (1.4-7.2 mg/dl to 1.46 mg/dl (0.8-2.6 mg/dl). Baseline and drop in creatinine were compared among patients treated with either surgical or pharmacological methods, and no statistical significance was found. CONCLUSION: Retroperitoneal fibrosis can be treated surgically and pharmacologically. Our study has shown similar success for both methods. Treatment should be specific for each patient in a multidisciplinary fashion.
dc.identifier.doi10.5262/tndt.2017.1003.10
dc.identifier.issn1300-7718
dc.identifier.urihttps://hdl.handle.net/11424/234230
dc.identifier.wosWOS:000419591800010
dc.language.isotur
dc.publisherTURK NEFROLOJI DIYALIZ TRANSPLANTASYON DERGISI
dc.relation.ispartofTURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectRetroperitoneal fibrosis
dc.subjectCreatinine
dc.subjectUreterolysis
dc.subjectTamoxifen
dc.subjectPREDNISONE
dc.subjectTAMOXIFEN
dc.subjectDIAGNOSIS
dc.titleExperience with Treatment of Retroperitoneal Fibrosis: Collaboration of Urology and Nephrology Departments for 26 years in Marmara University
dc.typearticle
dspace.entity.typePublication
local.avesis.idf276b987-7f72-4190-9122-9e6179293c44
local.import.packageSS17
local.indexed.atWOS
local.indexed.atSCOPUS
local.indexed.atTRDIZIN
local.journal.numberofpages6
oaire.citation.endPage310
oaire.citation.issue3
oaire.citation.startPage305
oaire.citation.titleTURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL
oaire.citation.volume26
relation.isAuthorOfPublication1e489bdb-418e-4500-a522-6c0babb604b9
relation.isAuthorOfPublication.latestForDiscovery1e489bdb-418e-4500-a522-6c0babb604b9

Files

Collections

Research Outputs